TABLE 1.

Patient characteristics and dosing regimens by drug

Patient characteristic	Value
No. (%) of males	50 (68.5)
Mean (SD) age (yr)	52.8 (21.7)
Mean (SD) wt (kg)	78.4 (19.2)
Mean (SD) APACHE II score	16.6 (6.5)
Mean (SD) ClCR (ml/min)	106.6 (50.8)
No. (%) receiving the following ceftazidime regimen:	18 (24.7)
2 g every 24 h (0.5-h infusion)	1 (5.5)
2 g every 12 h (0.5-h infusion)	2 (11.1)
2 g every 8 h (0.5-h infusion)	7 (38.9)
3 g every 24 h (continuous infusion)	7 (38.9)
4.5 g every 24 h (continuous infusion)	1 (5.5)
No. (%) receiving the following cefepime regimen:	55 (75.3)
1 g every 12 h (0.5-h infusion)	15 (27.2)
1 g every 8 h (0.5-h infusion)	10 (18.2)
2 g every 12 h (0.5-h infusion)	2 (3.6)
2 g every 8 h (0.5-h infusion)	20 (36.4)
2 g every 8 h (3-h infusion)	8 (14.5)